Coria, L. M., Saposnik, L. M., Pueblas Castro, C., Castro, E. F., Bruno, L. A., Stone, W. B., . . . Cassataro, J. (2022). A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations containing alum increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection in mice. Web
Citación estilo ChicagoCoria, Lorena M., et al. A Novel Bacterial Protease Inhibitor Adjuvant in RBD-based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection against SARS-CoV-2 Infection in Mice. 2022.
Cita MLACoria, Lorena M., et al. A Novel Bacterial Protease Inhibitor Adjuvant in RBD-based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection against SARS-CoV-2 Infection in Mice. 2022.